Drug intelligence / Profile preview

99mTc dextran 500

Development stage
Unknown
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Subcutaneous, Intravenous (less Common)
01

Overview

Technetium-99m dextran 500 is a radiopharmaceutical agent consisting of high molecular weight dextran (average molecular weight approximately 500,000 Daltons) labeled with the radioisotope technetium-99m. It is used primarily as a diagnostic imaging agent in nuclear medicine for lymphoscintigraphy and mapping of the lymphatic system, including sentinel lymph node detection. The mechanism involves intravenous or subcutaneous administration; the large size of the labeled macromolecule allows it to be retained within lymphatic vessels and nodes after local injection. The gamma emissions from technetium-99m enable external imaging using gamma cameras to visualize lymphatic drainage patterns and identify sentinel nodes for biopsy or surgical planning[1][5][6]. Dextrans are polysaccharides composed mainly of α-(1→6) linked glucose units with branching at α-(1→3) or α-(1→4). When radiolabeled with Tc-99m, they serve as inert carriers that do not undergo significant metabolism during imaging procedures.

Other names
technetium-99m labeled dextran 500technetium99m labeled dextran 500technetium 99m labeled dextran 500Tc-99m dextran 500Tc99m dextran 500Tc 99m dextran 500technetium Tc-99m-dextran (500)technetium-99m-dextran (MW ~500 kDa)

Beyond the preview

Go deeper on 99mTc dextran 500.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 99mTc dextran 500.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call